<0.001 |
colorectal carcinoma |
NA |
BeFree |
|
Detail |
<0.001 |
Diabetes |
NA |
BeFree |
|
Detail |
<0.001 |
diabetes mellitus |
NA |
BeFree |
|
Detail |
<0.001 |
Diabetes Mellitus, Non-Insulin-Dependent |
NA |
BeFree |
|
Detail |
<0.001 |
Diabetic Nephropathy |
NA |
BeFree |
|
Detail |
<0.001 |
Dwarfism |
NA |
BeFree |
|
Detail |
<0.001 |
Pituitary dwarfism |
NA |
BeFree |
|
Detail |
<0.001 |
endometriosis |
NA |
BeFree |
|
Detail |
<0.001 |
epidermodysplasia verruciformis |
NA |
BeFree |
|
Detail |
<0.001 |
epilepsy |
NA |
BeFree |
|
Detail |
<0.001 |
Epilepsy, Generalized |
NA |
BeFree |
|
Detail |
0.003 |
Epilepsies, Myoclonic |
NA |
LHGDN |
|
Detail |
<0.001 |
Exanthema |
NA |
BeFree |
|
Detail |
<0.001 |
Galactosemias |
NA |
BeFree |
|
Detail |
<0.001 |
glioblastoma |
NA |
BeFree |
|
Detail |
<0.001 |
granulosa cell tumor |
NA |
BeFree |
|
Detail |
0.004 |
hepatitis B |
Our lookback study suggests a low (0·2-3·3%) but measurable rate of HBV transmis... |
BeFree |
25234417 |
Detail |
0.004 |
HIV Infections |
NA |
BeFree |
|
Detail |
<0.001 |
hyperglycemia |
NA |
BeFree |
|
Detail |
<0.001 |
hyperprolactinemia |
NA |
BeFree |
|
Detail |
<0.001 |
hypopituitarism |
NA |
BeFree |
|
Detail |
0.001 |
male infertility |
NA |
BeFree |
|
Detail |
0.004 |
Klinefelter syndrome |
NA |
BeFree |
|
Detail |
<0.001 |
leukemia |
NA |
BeFree |
|
Detail |
0.002 |
Lupus Erythematosus, Systemic |
NA |
GAD |
|
Detail |
0.003 |
lymphoma |
NA |
BeFree,LHGDN |
|
Detail |
<0.001 |
Lymphoma, Non-Hodgkin |
NA |
BeFree |
|
Detail |
0.120 |
medulloblastoma |
NA |
CTD_human |
|
Detail |
<0.001 |
melanoma |
We identify BRD2 as an H2A.Z-interacting protein, levels of which are also eleva... |
BeFree |
26051178 |
Detail |
0.002 |
premature menopause |
NA |
BeFree |
|
Detail |
<0.001 |
Mental Retardation |
NA |
BeFree |
|
Detail |
<0.001 |
Monosomy |
NA |
BeFree |
|
Detail |
<0.001 |
spinal muscular atrophy |
NA |
BeFree |
|
Detail |
<0.001 |
obesity |
NA |
BeFree |
|
Detail |
<0.001 |
Obesity, Morbid |
NA |
BeFree |
|
Detail |
0.001 |
oligospermia |
NA |
BeFree |
|
Detail |
<0.001 |
osteoporosis |
NA |
BeFree |
|
Detail |
0.003 |
ovarian carcinoma |
This hypothesis is further supported by the recent understanding that: i) cancer... |
BeFree |
25269615 |
Detail |
0.005 |
Ovarian Diseases |
NA |
BeFree |
|
Detail |
<0.001 |
pituitary adenoma |
NA |
BeFree |
|
Detail |
0.013 |
Pituitary Diseases |
NA |
BeFree |
|
Detail |
<0.001 |
Pituitary Neoplasms |
NA |
BeFree |
|
Detail |
0.002 |
polycystic ovary syndrome |
Furthermore, this polymorphism was significantly associated with decreased 2-hou... |
BeFree |
25956367 |
Detail |
<0.001 |
prolactinoma |
NA |
BeFree |
|
Detail |
<0.001 |
pseudohypoparathyroidism |
NA |
BeFree |
|
Detail |
<0.001 |
retinoblastoma |
NA |
BeFree |
|
Detail |
<0.001 |
Kaposi sarcoma |
NA |
BeFree |
|
Detail |
<0.001 |
Seizures |
NA |
BeFree |
|
Detail |
<0.001 |
Androgen-Insensitivity Syndrome |
NA |
BeFree |
|
Detail |
0.002 |
Turner syndrome |
NA |
BeFree |
|
Detail |
<0.001 |
Virilism |
NA |
BeFree |
|
Detail |
<0.001 |
Virus Diseases |
NA |
BeFree |
|
Detail |
0.003 |
B-Cell Lymphomas |
NA |
LHGDN |
|
Detail |
<0.001 |
diffuse large B-cell lymphoma |
NA |
BeFree |
|
Detail |
<0.001 |
Lymphoma, Large-Cell, Follicular |
NA |
BeFree |
|
Detail |
0.002 |
ovarian hyperstimulation syndrome |
NA |
BeFree |
|
Detail |
0.006 |
Ovarian Failure, Premature |
Any defect in FSH-FSHR3-stem cell interaction in OSE may affect folliculogenesis... |
BeFree |
25269615 |
Detail |
<0.001 |
Polycystic Kidney, Autosomal Dominant |
NA |
BeFree |
|
Detail |
<0.001 |
polydactyly |
NA |
BeFree |
|
Detail |
<0.001 |
hyperandrogenism |
NA |
BeFree |
|
Detail |
<0.001 |
Congenital hypoplasia of adrenal gland |
NA |
BeFree |
|
Detail |
<0.001 |
Primary physiologic amenorrhea |
NA |
BeFree |
|
Detail |
<0.001 |
Secondary physiologic amenorrhea |
NA |
BeFree |
|
Detail |
<0.001 |
Muscular Dystrophy, Facioscapulohumeral |
NA |
BeFree |
|
Detail |
<0.001 |
panhypopituitarism |
NA |
BeFree |
|
Detail |
<0.001 |
Malignant neoplasm of lung |
NA |
BeFree |
|
Detail |
<0.001 |
CHARGE syndrome |
NA |
BeFree |
|
Detail |
<0.001 |
Streak gonad |
NA |
BeFree |
|
Detail |
<0.001 |
Liver cyst |
NA |
BeFree |
|
Detail |
<0.001 |
Classical galactosemia |
NA |
BeFree |
|
Detail |
<0.001 |
Reifenstein Syndrome |
NA |
BeFree |
|
Detail |
<0.001 |
idiopathic generalized epilepsy |
NA |
BeFree |
|
Detail |
0.007 |
Myoclonic Epilepsy, Juvenile |
NA |
BeFree,GAD,LHGDN |
|
Detail |
0.003 |
hypogonadotropic hypogonadism |
NA |
BeFree |
|
Detail |
<0.001 |
Impaired glucose tolerance |
NA |
BeFree |
|
Detail |
<0.001 |
Hyperplastic Polyp |
NA |
BeFree |
|
Detail |
<0.001 |
Fibrolamellar hepatocellular carcinoma |
NA |
BeFree |
|
Detail |
0.001 |
Adrenocorticotropic hormone (ACTH) deficiency (disorder) |
NA |
BeFree |
|
Detail |
<0.001 |
Adrenal hypertrophy or hyperplasia |
NA |
BeFree |
|
Detail |
<0.001 |
Ovarian dysgenesis |
NA |
BeFree |
|
Detail |
<0.001 |
pituitary carcinoma |
NA |
BeFree |
|
Detail |
<0.001 |
Growth Hormone-Secreting Pituitary Adenoma |
NA |
BeFree |
|
Detail |
<0.001 |
Gonadotroph adenoma |
NA |
BeFree |
|
Detail |
<0.001 |
Malignant neoplasm of prostate |
NA |
BeFree |
|
Detail |
<0.001 |
Hematologic Neoplasms |
NA |
BeFree |
|
Detail |
<0.001 |
idiopathic epilepsy |
NA |
BeFree |
|
Detail |
<0.001 |
Testicular dysfunction |
NA |
BeFree |
|
Detail |
<0.001 |
Anovulatory |
NA |
BeFree |
|
Detail |
<0.001 |
Dysmorphic features |
NA |
BeFree |
|
Detail |
0.001 |
Klinefelter's syndrome - male with more than two X chromosomes |
NA |
BeFree |
|
Detail |
<0.001 |
endometrial carcinoma |
NA |
BeFree |
|
Detail |
<0.001 |
Secondary malignant neoplasm of liver |
NA |
BeFree |
|
Detail |
0.001 |
Carcinogenesis |
NA |
BeFree |
|
Detail |
<0.001 |
Epithelial ovarian cancer |
NA |
BeFree |
|
Detail |
<0.001 |
breast carcinoma |
NA |
BeFree |
|
Detail |
<0.001 |
Carcinoma of lung |
NA |
BeFree |
|
Detail |
0.002 |
Carcinoma of bladder |
NA |
BeFree |
|
Detail |
<0.001 |
Ovarian failure |
NA |
BeFree |
|
Detail |
<0.001 |
early pregnancy |
NA |
BeFree |
|
Detail |
<0.001 |
Chromosome 3, monosomy 3p |
NA |
BeFree |
|
Detail |
<0.001 |
Spots on skin |
NA |
BeFree |
|
Detail |
<0.001 |
Hormone secreting pituitary neoplasms |
NA |
BeFree |
|
Detail |
<0.001 |
21-hydroxylase deficiency |
NA |
BeFree |
|
Detail |
<0.001 |
ovarian neoplasm |
NA |
BeFree |
|
Detail |
0.002 |
Primary hypogonadism |
NA |
BeFree |
|
Detail |
<0.001 |
Hurthle Cell Tumor |
NA |
BeFree |
|
Detail |
<0.001 |
West Nile viral infection |
NA |
BeFree |
|
Detail |
0.003 |
Malignant neoplasm of ovary |
This hypothesis is further supported by the recent understanding that: i) cancer... |
BeFree |
25269615 |
Detail |
<0.001 |
sarcoma |
NA |
BeFree |
|
Detail |
<0.001 |
Epithelioma |
NA |
BeFree |
|
Detail |
<0.001 |
Oncocytic Neoplasm |
NA |
BeFree |
|
Detail |
<0.001 |
Primary testicular failure |
NA |
BeFree |
|
Detail |
<0.001 |
Congenital absence of germinal epithelium of testes |
NA |
BeFree |
|
Detail |
<0.001 |
oxyphilic adenoma |
NA |
BeFree |
|
Detail |
<0.001 |
colorectal cancer |
NA |
BeFree |
|
Detail |
<0.001 |
Adrenal hyperplasia |
NA |
BeFree |
|
Detail |
<0.001 |
Azoospermia, Nonobstructive |
NA |
BeFree |
|
Detail |
<0.001 |
Follicle-stimulating hormone deficiency, isolated |
NA |
BeFree |
|
Detail |
<0.001 |
uterine corpus cancer |
NA |
BeFree |
|
Detail |
<0.001 |
Parvovirus B19 (disease) |
NA |
BeFree |
|
Detail |
<0.001 |
Hypergonadotropic amenorrhea |
NA |
BeFree |
|
Detail |
<0.001 |
aromatase excess syndrome |
NA |
BeFree |
|
Detail |
0.003 |
Leukemia, B-Cell |
NA |
LHGDN |
|
Detail |
<0.001 |
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency |
NA |
BeFree |
|
Detail |
<0.001 |
Ogden syndrome |
The X-linked lethal Ogden syndrome was the first reported human genetic disorder... |
BeFree |
25489052 |
Detail |
<0.001 |
Pseudohypoparathyroidism, Type Ia |
NA |
BeFree |
|
Detail |
<0.001 |
Diminished ovarian reserve |
NA |
BeFree |
|
Detail |
0.002 |
Spontaneous abortion |
NA |
GAD |
|
Detail |
0.004 |
adenoma |
NA |
BeFree |
|
Detail |
<0.001 |
congenital adrenal hyperplasia |
NA |
BeFree |
|
Detail |
0.002 |
Alzheimer's disease |
NA |
GAD |
|
Detail |
0.002 |
amenorrhea |
POI was defined as amenorrhea of more than 4 months with increased FSH before th... |
BeFree |
25750103 |
Detail |
0.003 |
asthma |
NA |
BeFree,GAD |
|
Detail |
0.004 |
azoospermia |
NA |
BeFree,GAD |
|
Detail |
<0.001 |
Bladder Neoplasm |
Patients with urinary bladder neoplasms who had been followed up for a 5-year pe... |
BeFree |
17469025 |
Detail |
0.002 |
Malignant neoplasm of urinary bladder |
NA |
BeFree |
|
Detail |
<0.001 |
Bladder Neoplasm |
NA |
BeFree |
|
Detail |
<0.001 |
Malignant neoplasm of breast |
NA |
BeFree |
|
Detail |
<0.001 |
Cachexia |
NA |
BeFree |
|
Detail |
<0.001 |
Malignant neoplasm of endometrium |
NA |
BeFree |
|
Detail |
<0.001 |
Non-small cell lung carcinoma |
NA |
BeFree |
|
Detail |